The resolution urges the Governor of New Jersey to instruct relevant state departments and agencies to take action aimed at reducing fatalities associated with atherosclerotic cardiovascular disease (ASCVD), which is the leading cause of death in the United States. With approximately 21 million Americans diagnosed with ASCVD and nearly 70 million adults having elevated levels of low-density lipoprotein cholesterol (LDL-C), the resolution highlights the significant health risks and economic burden posed by this condition. In New Jersey alone, over half a million adults have been diagnosed with conditions related to ASCVD, leading to an estimated annual expenditure of $3.39 billion on related medical care.

To address this public health crisis, the resolution calls for a comprehensive review and update of existing policies by state agencies, as well as collaboration with federal and national organizations to enhance cardiovascular health screening programs. Additionally, it urges the Department of Health to revise the state's cardiovascular plan to improve the quality of care for ASCVD patients, focusing on better screening, treatment, and monitoring to achieve improved health outcomes. The resolution aims to mobilize state resources and expertise to combat the rising incidence of ASCVD and its associated fatalities.